We are live on ! Find out more
FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Fund
S&P 500
This Quarter Est. Return
-15.85%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$178M
AUM Growth
-$43.6M
Cap. Flow
-$2.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$1M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 40.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics
AIMT
$56.8M 31.92%
2,726,568
– –
AERI
2
DELISTED
Aerie Pharmaceuticals
AERI
$49.4M 27.79%
1,672,714
– –
INSM icon
3
Insmed
INSM
$23.2B
$24.5M 13.75%
955,462
+36,026
+4% +$1M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$18.7M 10.5%
1,488,444
– –
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
$18.7M 10.5%
1,586,220
– –
XLRN
6
DELISTED
Acceleron Pharma
XLRN
$7.75M 4.36%
188,602
– –
TWST icon
7
Twist Bioscience
TWST
$5.62B
$2.11M 1.19%
72,849
– –
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-717,133
Closed -$3.8M

Similar funds

AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
AC
Amia Capital London, United Kingdom $32.1M AUM 0.56% 1-Year Est. Return
QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return
NAM
Nationwide Asset Management Columbus, Ohio $25.1M AUM 13.37% 1-Year Est. Return
MSKCC
Memorial Sloan Kettering Cancer Center New York $24.6M AUM 10.16% 1-Year Est. Return
BRC
Bishop Rock Capital New York $24.3M AUM 20.73% 1-Year Est. Return

Foresite Capital Management II's Q2 2019 Portfolio in Review

As of Q2 2019, Foresite Capital Management II held 8 positions worth $178M, down 20% from $221M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management II's Q2 2019 filing shows 1 increased and 1 closed positions. The largest sale was BioDelivery Sciences International, Inc., an estimated $3.8M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier.

  • Foresite Capital Management II added most to Insmed in Q2 2019, an estimated $1M increase.
  • Foresite Capital Management II fully exited BioDelivery Sciences International, Inc. in Q2 2019, selling an estimated $3.8M.
  • Foresite Capital Management II's ten largest holdings make up 100% of its $178M portfolio in Q2 2019.
  • Foresite Capital Management II opened 0 new positions and closed 1 in Q2 2019.
  • Foresite Capital Management II's portfolio value fell 20% quarter-over-quarter to $178M.

Based on Foresite Capital Management II's 13F filing for Q2 2019, filed 13 Aug 2019.